Quibim, a global company pioneering imaging biomarkers for precision medicine, is today announcing the launch of a new product, QP-Liver, which improves the diagnosis of diffuse liver diseases through ...
Hosted on MSN
Dual-mode MRI nanoprobe mimics biological processes to pinpoint early fibrosis in fatty liver disease
A research team has developed an innovative biomimetic dual-mode magnetic resonance imaging (MRI) nanoprobe for detecting early-stage liver fibrosis in non-alcoholic fatty liver disease (NAFLD). The ...
Full-body MRIs are all the rage. We take a look at three major companies offering such testing.
Hepatocellular carcinoma (HCC) remains a primary cause of cancer-related mortality, particularly for individuals living with cirrhosis or chronic hepatitis B. While many expert associations recommend ...
Feasibility study data at 12-22% liver fat cutoffs validate TAEUS as a potential low-cost, point-of-care alternative to MRI-PDFF for patient stratification and trial monitoring ENDRA Life Sciences Inc ...
Matt Fuchs lives in Maryland and writes about health, science, and technology. Matt Fuchs lives in Maryland and writes about health, science, and technology. Calvin Sun was a healthy 37-year-old when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results